Resultados da Busca
- 1
- 2
- > Seguinte
-
Anna-Lena Engwall - Global Commercial Vice President & Franchise Head, Cardiovascular & Renal, Metabolic - posee un Bachelor of Science in Nursing de Karolinska Institute.AstraZeneca - Farmacêutica - Reino Unido
-
Jan Lundberg - Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Ardelyx - Biotecnologia - Estados Unidos
-
Carl Kilander - Director - has a Doctor of Medicine from Karolinska Institute and PhD from Karolinska Institute.Adcendo - Biotecnologia - Dinamarca
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.A2 Biotherapeutics - Biotecnologia - Estados Unidos
-
Jan Lundberg - Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Anocca - Biotecnologia - Suécia
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Arrakis Therapeutics - Biotecnologia - Estados Unidos
-
Anders Ekblom - Chairman of the Board - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Alligator Bioscience - Biotecnologia - Suécia
-
Jan Lundberg - Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Ferring Pharmaceuticals - Farmacêutica - Suíça
-
Johan Luthman - Executive Vice President and Head of Research & Development - has a PhD, Basic Dentistry, Medicine and Neuroscience from Karolinska Institute and Doctor of Dental Surgery from Karolinska Institute.Lundbeck - Farmacêutica - Dinamarca
-
Yilmaz Mahshid - Chief Financial Officer - has a PhD in Medical Biochemistry and Biophysics from Karolinska Institute and Master in Toxicology from Karolinska Institute.Desiree Luthman - Vice President, Global Regulatory Affairs - posee un Doctor of Dental Surgery de Karolinska Institute.Egetis Therapeutics - Biotecnologia - Suécia
-
Anders Ekblom - Non-Executive Director - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Mereo BioPharma - Farmacêutica - Reino Unido
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Flare Therapeutics - Biotecnologia - Estados Unidos
-
Per Lundin - Chief Executive Officer and Director - has a PhD in Medical Science from Karolinska Institute and Licentiate in Neurochemistry from Stockholm University.Evox Therapeutics - Biotecnologia - Reino Unido
-
Jarl Jungnelius - Board Member - posee un Doctor of Medicine de Karolinska Institute.Oncopeptides - Biotecnologia - Suécia
-
Mikael Nygard - Vice President, Business Development - has a PhD in Neuroscience from Karolinska Institute and Master of Sciences in Pharmacy from Uppsala University.Vicore Pharma - Farmacêutica - Suécia
-
Yilmaz Mahshid - Director - has a PhD in Medical Biochemistry and Biophysics from Karolinska Institute and Master in Toxicology from Karolinska Institute.Malene Jensen - Vice President, Clinical Development - has a PhD in Clinical Neuroscience from Karolinska Institute and Master of Science in Molecular Biology from Stockholm University.Pia Baumann - Chief Medical Officer - posee un PhD in Oncology de Karolinska Institute.Medivir - Biotecnologia - Suécia
-
Claes Lindh - Chief Medical Officer - posee un PhD in Prostate Cancer Pathology de Karolinska Institute.Inify Laboratories - Biotecnologia - Suécia
-
Hans Basun - Senior Director Clinical Development - posee un Medical Doctorate de Karolinska Institute.Anna-Lena Engwall - Director - posee un Bachelor of Science in Nursing de Karolinska Institute.BioArctic - Biotecnologia - Suécia
-
Jakob Loven - Board Member - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.IconOVir Bio - Biotecnologia - Estados Unidos
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Boundless Bio - Biotecnologia - Estados Unidos
-
Jan Lundberg - Independent Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Metabolon - Biotecnologia - Estados Unidos
-
Anna-Karin Maltais - Chief Scientific Officer - has a PhD in Immunobiology and Tumor Immunology, Immunotherapy, Vaccines from Karolinska Institute and Master of Science in Biology, Mathematical and Science Program from Uppsala University.XNK Therapeutics - Biotecnologia - Suécia
-
Anders Ekblom - Chairman of the Board - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Elypta - Biotecnologia - Suécia
- 1
- 2
- > Seguinte